1.75
price up icon4.17%   0.07
after-market Handel nachbörslich: 1.75
loading
Schlusskurs vom Vortag:
$1.68
Offen:
$1.63
24-Stunden-Volumen:
1.03M
Relative Volume:
0.48
Marktkapitalisierung:
$29.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.24M
KGV:
-2.2981
EPS:
-0.7615
Netto-Cashflow:
$-4.79M
1W Leistung:
+5.42%
1M Leistung:
+43.44%
6M Leistung:
+47.06%
1J Leistung:
-65.07%
1-Tages-Spanne:
Value
$1.61
$1.77
1-Wochen-Bereich:
Value
$1.61
$2.09
52-Wochen-Spanne:
Value
$0.73
$4.12

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name
Firmenname
Mira Pharmaceuticals Inc
Name
Telefon
813-369-5150
Name
Adresse
1200 BRICKELL AVENUE, MIAMI
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MIRA's Discussions on Twitter

Vergleichen Sie MIRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MIRA
Mira Pharmaceuticals Inc
1.75 30.66M 0 -11.24M -4.79M -0.7615
Drug Manufacturers - General icon
LLY
Lilly Eli Co
776.44 692.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.93 373.35B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
187.11 329.24B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.83 231.66B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
66.78 298.68B 43.59B 15.04B 10.74B 3.3766

Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten

pulisher
Jul 22, 2025

MIRA Pharmaceuticals Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is MIRA Pharmaceuticals Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives MIRA Pharmaceuticals Inc. stock priceRapid-fire capital growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

What analysts say about MIRA Pharmaceuticals Inc. stockExponential return rates - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

why mira pharmaceuticals inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will MIRA Pharmaceuticals Inc. stock split in the near futureTop ROI Selections - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How MIRA Pharmaceuticals Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why MIRA Pharmaceuticals Inc. stock attracts strong analyst attentionInvestor Favorite Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MIRA Pharmaceuticals Inc. stock price move sharplyFree Expert Investment Advice - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

MIRA Stocks Surge: Are They Viable Investments? - StocksToTrade

Jul 14, 2025
pulisher
Jul 13, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jul 13, 2025
pulisher
Jul 12, 2025

MIRA Pharmaceuticals Raises $2M Through Stock Sale - TipRanks

Jul 12, 2025
pulisher
Jul 11, 2025

MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition - Pocono Record

Jul 11, 2025
pulisher
Jul 11, 2025

Mira Says Preclinical Results of Obesity, Nicotine Addiction Treatment Drug Show Reversal of Anxiety-Like Behavior - MarketScreener

Jul 11, 2025
pulisher
Jul 11, 2025

MIRA’s obesity drug candidate shows anti-anxiety effects in study By Investing.com - Investing.com India

Jul 11, 2025
pulisher
Jul 11, 2025

Mira Pharmaceuticals reports preclinical data on SKNY-1 candidate - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

MIRA’s obesity drug candidate shows anti-anxiety effects in study - Investing.com

Jul 11, 2025
pulisher
Jul 10, 2025

MIRA Pharmaceuticals Reports Promising SKNY-1 Preclinical Results - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Mira Pharmaceuticals reports preclinical results for SKNY-1 drug candidate - Investing.com

Jul 10, 2025

Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$48.75
price up icon 1.71%
$110.17
price up icon 1.75%
drug_manufacturers_general PFE
$25.14
price up icon 3.63%
$305.69
price up icon 3.32%
drug_manufacturers_general MRK
$81.61
price up icon 2.90%
drug_manufacturers_general NVO
$66.78
price up icon 2.87%
Kapitalisierung:     |  Volumen (24h):